Home > Healthcare & Medical Devices > U.S. Clinical Nutrition Market

U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI4514
  • Published Date: Mar 2022
  • Report Format: PDF

Industry Overview

U.S. Clinical Nutrition Market size surpassed USD 11,734 million in 2021 and is projected to register over 8.1% CAGR between 2022 and 2028. Nutrition has garnered wide scientific and clinical interest during the past decades. Some of the major drivers that are anticipated to contribute to the market growth include increasing prevalence of metabolic and chronic diseases, rise in geriatric population, and unhealthy dietary habits such as high junk food consumption that leads to malnourishment in the U.S.

U.S. Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF

Increasing adoption of home healthcare model has further stimulated rapid advances in design, development, and clinical application of nutritional support. Other factors such as growing diabetic patient pool is acting as major growth driver for the market leading to increased product adoption in the country.

For instance, according to the national diabetic statistic report generated by the Centers for Disease Control and Prevention (CDC) in 2022, around 37.3 million people suffered from diabetes, that makes 11.3% of the total U.S. population. Thus, the above-mentioned factors will contribute to boosting the demand for clinical nutrition products in the U.S.

Clinical nutrition involves a group of pharmacological agents that help in providing essential nutrients to the body required in effective functioning and over-all well-being of a patient. The reason for providing nutrition assistance includes reducing the consequences of semi-starvation and improving the natural history or response to treatment for an illness. Clinical nutrition support is plainly necessary when food intake or nutrient assimilation is restricted for an extended period, in order to prevent starvation and other fatal outcomes.

However, one of the restricting elements in U.S. clinical nutrition market is the stringent government regulation that needs to be strictly adhered to by entities operating in the industry. The clinical nutrition products are mandated to comply with the labelling requirements amended by the U.S. Food and Drug Administration (U.S. FDA). These mandates include issued guidelines as per the FD&C Act.

Further, several other requirements including the current good manufacturing practice (CGMP) and others are required to be adhered to. According to a report by the American Nutrition Association, hundreds of state bills addressing nutrition practitioners are presented each year around the country. These bills frequently have a direct impact on nutrition practitioners’ capacity to practise, gain licencing, or work and volunteer in various roles. All such tighter regulations are expected to hinder the market demand.

The pandemic has become an unexpected public health threat, with considerable implications for the clinical nutrition sector. Over millions of people have been afflicted by the coronavirus outbreak, which has resulted in considerable deaths in the U.S. Scheduled appointments and a majority of other disease conditions were referred to as non-emergent.

Owing to this, the U.S. clinical nutrition market has been affected due the ongoing COVID-19 pandemic. However, there has been an increase in demand for nutritional management as the need for the dietary supplement for several micro and macro- nutrients was widely needed for patients suffering from COVID-19.

According to a report published in the NCBI in 2020, the need of adequate nutrition and dietary patterns during the COVID- 19 pandemic has been addressed widely, not only as a means of preventing the occurrence of non-communicable diseases, which can lead to more severe infections, but also as a means of regulating the inflammatory status of the patients.

Furthermore, overlooking the relevance of nutrition in COVID-19 patients can have a significant impact on patient’s prognosis. Thus, the hospitals and clinics have raised the provision of healthcare solutions for patients that require disease-precise nutrients. Such traits are poised to upsurge the demand for clinical nutrition management in patients, thereby uplifting the market expansion.

Increasing metabolic disorders and other chronic diseases in U.S. is predicted to drive the market statistics

The rising prevalence of chronic diseases such as cardiovascular diseases (CVDs), cancer, respiratory diseases, diabetes, etc. in the U.S will drive market trends over the forecast period. For instance, cancer has a major impact in the U.S. and across the world. The National Cancer Institute published an epidemiology report that suggested the instances of cancer in the U.S., an estimated 16,850 children and adolescents were diagnosed with cancer in 2020.

Patients with cancer suffer with cachexia related muscle wasting and protein calorie malnutrition. According to a journal published in Science direct in 2020, Cachexia was observed in 80% of the cancer patients and was responsible for around 22%-30% deaths due to cancer. Clinical nutrition has been instrumental in improving appetite and countering metabolic abnormalities in such chronic diseases.

Surging adoption of infant nutritional products is anticipated to stimulate the market statistics positively

U.S. Clinical Nutrition Market Size By Product

Get more details on this report - Request Free Sample PDF

Based on product, the U.S. clinical nutrition market is segmented as infant nutrition, enteral nutrition, and parenteral nutrition. The infant nutrition segment accounted for over USD 6,574 million in 2021 and is set to record a robust CAGR during the forecast period. The majority share of the segment is owing to the increased number of premature deliveries in the U.S. Preterm neonates nutrition needs differ from that of full-term babies. Administration of clinical nutrition combats the risk of growth and developmental disabilities and provide good metabolism and immunity support in the children.

According to a 2021 report provided by the CDC, the preterm birth and low birth weight accounted for about 17% of infant deaths in the country. According to the World Health Organization (WHO) report, in 2018, around 547,400 premature births were recorded in the U.S. Thus, all the factors mentioned above will propel the segment expansion.

Increasing prevalence of intolerances and allergies among children will drive the business revenue

Based on consumer, the market is segmented as adult and pediatric. The pediatric segment garnered a revenue of USD 6,935 million in 2021. The segmental growth is attributed to rising instances of food allergies and intolerances among children. The recent 2022 report from the CDC suggests that around 8% of the children in the U.S. suffer from food allergies resulting in anaphylaxis. The allergic reactions leave the patients deficient of the essential nutrition that can be catered through the administration of clinical nutrition.

Furthermore, data from a report by the NCBI suggests that Parvalbumin is the major fish allergen that counts for 90% of the IgE mediated reactions. Nutritional supplements with algal-derived omega-3 fatty acids can be dispensed to deliver vital nutrients. This provides a potential sector for market participants to invest and strengthen their presence in the country. Thus, the afore-mentioned factors are expected to boost the U.S. market forecasts.

Increasing prevalence of gastrointestinal disorders in U.S. is projected to enhance the industry landscape

U.S. Clinical Nutrition Market Share By Application

Get more details on this report - Request Free Sample PDF

Based on application, the U.S. clinical nutrition market is segmented into cancer, metabolic disorders, neurological diseases, gastrointestinal disorders, and others. The gastrointestinal disorders segment held a revenue of around USD 3,015 million in 2021. The growing prevalence of gastrointestinal disorders such as enterocutaneous fistulas, inflammatory bowel disease, pancreatitis is observed in the recent years.

For instance, a statistical data reviewed in 2021 by the CDC reports 37.2 million visits to clinics for digestive ailments in the U.S. This has increased the demand for clinical nutrition as it aids in providing patients with immediate nutritional support. The parenteral mode of administration of the injectables helps in patients suffering from ailments related to the ingestion or digestion. According to an epidemiology study of January 2021, cited in the NCBI PUBMED, more than 40% of people worldwide are suffering from functional gastrointestinal disorders and a considerable chunk of this comes from U.S. Thus, all the above-mentioned variables are set to fuel the business expansion.

Rising preference for retail stores among consumers will augment market demand

Based on distribution channel, the market is segmented as retail stores, pharmacies & drug stores, online channels, and others. The retail stores segment was valued at over USD 4,949 million in 2021 and is anticipated to witness healthy growth during the analysis period. The majority market share of the segment is attributed to the accessibility, brand familiarity and availability of nutritional products.

Additionally, price and promotion information influences purchase intentions and choices of consumers. Clinical nutrition is a class of nutraceuticals that requires professional supervision taking dietary habits, metabolic syndromes, and underlying complications into consideration. Thus, the components mentioned above play a significant role in the buying choices of a consumer that leads to segmental expansion.

Industry players are focusing on new product launches that will boost the market growth

Some of the key industry players operating in the U.S. clinical nutrition industry include Abbott Laboratories (Abbott Nutrition), B Braun Melsungen AG, Baxter International Inc., Fresenius Kabi, Mead Johnson (Reckitt Benckiser), Nestle Health Science, Perrigo, Pfizer, Inc., Danone, Hero Nutritionals Inc. These industry players are participating in several growth strategies with continued innovations and technological advancements, strategic acquisitions, and new product launches, to sustain the robust competition in the industry.

Recent industry developments:

  • In September 2021, Abbott Laboratories (Abbott Nutrition) announced the launch of PediaSure Harvest and Ensure Harvest, the enteral nutrition range comprising of plant- based protein and organic fruits and vegetables providing 25 essential vitamins and minerals. This launch helped the firm to contribute to increasing market share in the U.S. clinical nutrition industry.
  • In September 2020, Baxter International Inc. announced FDA approval of Clinimix, injection and Clinimix E injections. These parenteral nutrition formulations cater to reach protein target easily. The new product introduction enabled the company to strengthen its product portfolio.

U.S. clinical nutrition market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Product

  • Infant Nutrition
    • Milk Based
    • Soy Based
    • Organic formulas
    • Others
  • Enteral Nutrition
    • Standard composition
    • Disease specific composition
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others

By Consumer

  • Pediatric
  • Adult

By Application

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

U.S. market for clinical nutrition value surpassed USD 11,734 million in 2021 and is anticipated to grow at a CAGR of 8.1% from 2022 to 2028 owing to rising prevalence of metabolic and chronic diseases.

The market revenue from infant nutrition exceeded USD 6,574 million in 2021 and is expected to grow at an appreciable CAGR considering the surging number of premature deliveries in the U.S.

The industry share from gastrointestinal disorders accounted for around USD 3,015 million in 2021 and is estimated to depict lucrative growth driven by the soaring prevalence of pancreatitis, inflammatory bowel disease, enterocutaneous fistulas, and other health conditions.

Leading players in the U.S. clinical nutrition industry comprise Baxter International Inc., Nestle Health Science, Danone, Abbott Laboratories (Abbott Nutrition), Hero Nutritionals Inc., and others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 67
  • Countries covered: 1
  • Pages: 80

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount